4//SEC Filing
Burgess Julie 4
Accession 0001209191-24-001042
CIK 0001807120other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:41 PM ET
Size
5.8 KB
Accession
0001209191-24-001042
Insider Transaction Report
Form 4
Burgess Julie
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2024-01-02+110,000→ 110,000 totalExercise: $2.54Exp: 2034-01-01→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2025, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months.
Documents
Issuer
Design Therapeutics, Inc.
CIK 0001807120
Entity typeother
Related Parties
1- filerCIK 0001883722
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:41 PM ET
- Size
- 5.8 KB